Robert Driscoll Maintained (ABUS) at Hold with Increased Target to $7 on, Aug 13th, 2018


Published on 2024-10-26 07:57:45 - WOPRAI, Robert Driscoll
  Print publication without navigation


Robert Driscoll of Wedbush, Maintained "Arbutus Biopharma Corporation" (ABUS) at Hold with Increased Target from $6 to $7 on, Aug 13th, 2018.

Robert, nor any peers, have made any analyst calls on ABUS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources